...
首页> 外文期刊>Saudi Pharmaceutical Journal >Somatostatin receptors as a new active targeting sites for nanoparticles
【24h】

Somatostatin receptors as a new active targeting sites for nanoparticles

机译:生长抑素受体作为纳米颗粒的新活性靶向位点

获取原文

摘要

The delivery of nanoparticles through receptor-mediated cell interactions has nowadays a major attention in the area of drug targeting applications. This specific kind of targeting is mediated by localized receptors impeded into the target site with subsequent drugs internalization. Hence, this type of interaction would diminish side effects and enhance drug delivery efficacy to the target site. Somatostatin receptors (SSTRs) are one type of G protein-coupled receptors, which could be active targeted for various purposes. There are five SSTRs types (SSTR1-5) which are localized at various organs in the body and spread into different tissues. SSTRs could be considered as a promising target to various nanoparticles which is facilitated when nanoparticles are modified through specific ligand or coating to allow better binding. This review discusses the exploration of SSTRs for active targeting of nanoparticles with certain emphasize on their interaction at the cellular level.
机译:如今,通过受体介导的细胞相互作用来递送纳米颗粒已经成为药物靶向应用领域的主要关注点。这种特定类型的靶向作用是通过随后的药物内化作用阻碍进入靶位点的局部受体介导的。因此,这种类型的相互作用将减少副作用并增强向靶部位的药物递送功效。生长抑素受体(SSTRs)是一种G蛋白偶联受体,可以针对多种目的进行主动靶向。有五种SSTR类型(SSTR1-5),它们位于体内的各个器官中,并扩散到不同的组织中。可以将SSTRs视为各种纳米颗粒的有前途的目标,当通过特定的配体或涂层修饰纳米颗粒以实现更好的结合时,SSTRs会变得容易。这篇综述讨论了SSTRs主动靶向纳米粒子的探索,并特别强调了它们在细胞水平上的相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号